Mahopac, NY, United States of America

Andrew R Blight

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Andrew R. Blight

Introduction

Andrew R. Blight is a notable inventor based in Mahopac, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release aminopyridine compositions. With a total of six patents to his name, Blight's work has the potential to impact the treatment of various neurological diseases.

Latest Patents

Among his latest patents, Blight has developed methods for using sustained release aminopyridine compositions. This pharmaceutical composition includes a therapeutically effective amount of aminopyridine dispersed in a release matrix. One of his notable inventions is a stable, sustained-release oral dosage formulation, such as a tablet, which provides a therapeutically effective plasma level of aminopyridine for approximately 12 hours. This formulation is particularly useful in treating neurological diseases, including multiple sclerosis. Additionally, he has patented a method for selecting individuals based on their responsiveness to treatment with a sustained release fampridine composition.

Career Highlights

Blight is currently associated with Acorda Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving treatment options for patients suffering from neurological conditions. His contributions have been instrumental in advancing the understanding and application of aminopyridine in therapeutic settings.

Collaborations

Blight has collaborated with notable colleagues, including Ron Cohen and Thomas C. Wessel. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Andrew R. Blight's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to improving patient care. His work in sustained release aminopyridine compositions represents a significant advancement in the treatment of neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…